PCSK9 Inhibition in high risk patients
EAS Academy. Steg G. 05/07/18; 217754 Topic: Therapy
Gabriel Steg
Gabriel Steg
Contributions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies